Jerry J. Buccafusco

11.1k total citations · 1 hit paper
200 papers, 8.3k citations indexed

About

Jerry J. Buccafusco is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Jerry J. Buccafusco has authored 200 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Molecular Biology, 78 papers in Cellular and Molecular Neuroscience and 71 papers in Pharmacology. Recurrent topics in Jerry J. Buccafusco's work include Nicotinic Acetylcholine Receptors Study (84 papers), Cholinesterase and Neurodegenerative Diseases (67 papers) and Receptor Mechanisms and Signaling (55 papers). Jerry J. Buccafusco is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (84 papers), Cholinesterase and Neurodegenerative Diseases (67 papers) and Receptor Mechanisms and Signaling (55 papers). Jerry J. Buccafusco collaborates with scholars based in United States, Czechia and United Kingdom. Jerry J. Buccafusco's co-authors include Alvin V. Terry, William James Jackson, Moussa B. H. Youdim, Mark Prendergast, Henry E. Brezenoff, Mahanandeeshwar Gattu, Michael Decker, Robert S. Aronstam, Dennis C. Marshall and Edward D. Levin and has published in prestigious journals such as Circulation Research, Journal of Neurophysiology and Brain Research.

In The Last Decade

Jerry J. Buccafusco

198 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

2003 927 citations Alvin V. Terry, Jerry J. Buccafusco Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerry J. Buccafusco United States	51	4.0k	3.0k	2.3k	1.6k	1.3k	200	8.3k
Alvin V. Terry United States	52	3.8k 0.9×	2.8k 0.9×	2.0k 0.8×	1.1k 0.7×	1.2k 0.9×	205	8.7k
Arnold Lippa United States	34	3.1k 0.8×	4.6k 1.5×	2.7k 1.1×	1.2k 0.8×	2.4k 1.8×	91	8.5k
Alan M. Palmer United States	40	2.4k 0.6×	2.4k 0.8×	2.2k 0.9×	2.1k 1.3×	947 0.7×	98	8.4k
Giancarlo Pepeu Italy	58	3.9k 1.0×	5.4k 1.8×	3.0k 1.3×	2.0k 1.2×	2.3k 1.8×	245	10.4k
Edna F. R. Pereira United States	47	6.3k 1.6×	3.7k 1.2×	2.7k 1.2×	735 0.5×	742 0.6×	106	10.3k
Bernard Beer United States	30	3.1k 0.8×	4.6k 1.5×	2.7k 1.1×	1.4k 0.8×	2.5k 1.9×	58	8.8k
Roger D. Porsolt France	33	3.2k 0.8×	5.6k 1.8×	1.5k 0.6×	1.7k 1.0×	1.2k 0.9×	89	12.0k
Ezio Giacobini United States	37	2.4k 0.6×	1.6k 0.5×	2.8k 1.2×	2.3k 1.4×	630 0.5×	148	8.0k
Christian C. Felder United States	65	7.3k 1.8×	7.8k 2.6×	5.0k 2.1×	1.2k 0.8×	1.3k 1.0×	158	14.0k
Tangui Maurice France	58	7.0k 1.7×	4.7k 1.6×	1.9k 0.8×	2.0k 1.2×	516 0.4×	206	11.6k

Countries citing papers authored by Jerry J. Buccafusco

Since Specialization

Citations

This map shows the geographic impact of Jerry J. Buccafusco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry J. Buccafusco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry J. Buccafusco more than expected).

Fields of papers citing papers by Jerry J. Buccafusco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry J. Buccafusco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry J. Buccafusco. The network helps show where Jerry J. Buccafusco may publish in the future.

Co-authorship network of co-authors of Jerry J. Buccafusco

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry J. Buccafusco. A scholar is included among the top collaborators of Jerry J. Buccafusco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry J. Buccafusco. Jerry J. Buccafusco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Terry, Alvin V., Jerry J. Buccafusco, Debra A. Gearhart, et al.. (2010). Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience. 176. 237–253. 25 indexed citations

Ariga, Toshio, Makoto Yanagisawa, Chandramohan Wakade, et al.. (2010). Ganglioside Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease: Expression of Chol-1α Antigens in the Brain. ASN NEURO. 2(4). e00044–e00044. 32 indexed citations

Mitchell, Meghan, et al.. (2010). RAGE and Aβ Immunoglobulins: Relation to Alzheimer’s disease-related cognitive function. Journal of the International Neuropsychological Society. 16(4). 672–678. 7 indexed citations

Buccafusco, Jerry J.. (2009). Emerging cognitive enhancing drugs. Expert Opinion on Emerging Drugs. 14(4). 577–589. 11 indexed citations

Buccafusco, Jerry J., et al.. (2008). Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task. Psychopharmacology. 202(1-3). 477–485. 10 indexed citations

Prendergast, Mark, Rachel L. Self, Katherine J. Smith, et al.. (2007). Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity. Neuroscience. 146(1). 330–339. 62 indexed citations

Buccafusco, Jerry J., et al.. (2007). MHP-133, a Drug with Multiple CNS Targets: Potential for Neuroprotection and Enhanced Cognition. Neurochemical Research. 32(7). 1224–1237. 7 indexed citations

Arias, Esperanza, et al.. (2005). Effect of Amyloid Peptides on the Increase in TrkA Receptor Expression Induced by Nicotine In Vitro and In Vivo. Journal of Molecular Neuroscience. 27(3). 325–336. 12 indexed citations

Buccafusco, Jerry J., et al.. (2004). The Importance of Brainstem Cholinergic Neurons in the Pressor Response to Cocaine. Journal of Pharmacology and Experimental Therapeutics. 312(1). 179–191. 5 indexed citations

10.

Buccafusco, Jerry J.. (2004). Cognitive Enhancing Drugs. Birkhäuser Basel eBooks. 29 indexed citations

11.

Buccafusco, Jerry J., et al.. (2004). Role of α7 Nicotinic Acetylcholine Receptors in the Pressor Response to Intracerebroventricular Injection of Choline: Blockade by Amyloid Peptide Aβ1-42. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1206–1212. 21 indexed citations

12.

Terry, Alvin V. & Jerry J. Buccafusco. (2003). The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development. Journal of Pharmacology and Experimental Therapeutics. 306(3). 821–827. 927 indexed citations breakdown →

13.

Griffin, Susan, Cynthia A. Lemere, Todd M. Morgan, et al.. (2003). 33rd Annual Meeting of the Society for Neuroscience. 28(12). 799–801. 21 indexed citations

14.

Stone, J. D., Alvin V. Terry, James R. Pauly, Mark Prendergast, & Jerry J. Buccafusco. (2000). Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Research. 882(1-2). 9–18. 23 indexed citations

15.

Prendergast, Mark & Jerry J. Buccafusco. (1998). (–)-Nicotine increases mRNA encoding G3PDH and the vesicular acetylcholine transporter in vivo. Neuroreport. 9(7). 1385–1389. 13 indexed citations

16.

Prendergast, Mark, Jerry J. Buccafusco, & Alvin V. Terry. (1997). Nitric Oxide Synthase Inhibition Impairs Spatial Navigation Learning and Induces Conditioned Taste Aversion. Pharmacology Biochemistry and Behavior. 57(1-2). 347–352. 61 indexed citations

17.

Briggs, Clark A., David J. Anderson, Jorge D. Brioni, et al.. (1997). Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo. Pharmacology Biochemistry and Behavior. 57(1-2). 231–241. 171 indexed citations

18.

Arnerić, Stephen P., James P. Sullivan, Michael Decker, et al.. (1995). Potential Treatment of Alzheimer Disease Using Cholinergic Channel Activators (ChCAs) with Cognitive Enhancement, Anxiolytic-like, and Cytoprotective Properties. Alzheimer Disease & Associated Disorders. 9. 50–61. 32 indexed citations

19.

Ray, P. G., Kimford J. Meador, David W. Loring, et al.. (1991). Effects of scopolamine on visual evoked potentials in aging and dementia. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 80(5). 347–351. 18 indexed citations

20.

Trimarchi, Giancarlo, et al.. (1989). Contribution of pre- and post-synaptic components to heightened central cholinergic activity in spontaneously hypertensive rats. Neuropharmacology. 28(4). 379–386. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact